Circular RNA–microRNA–mRNA network identified circ_0007618 and circ_0029426 as new valuable biomarkers for lung adenocarcinoma

References

• Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 2018;9(2):117.
   PubMedGoogle Scholar
• Isla D, de Castro J, Garcia-Campelo R, et al. Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus. Clin Transl Oncol. 2020;22(5):759–771.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao X, Wang Y, et al. circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis. 2020;11(1):32.
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhang S, Chen Z, et al. CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1. Cell Death Dis. 2019;10(12):885.
   PubMedGoogle Scholar
• Li R, Jiang J, Shi H, et al. CircRNA: a rising star in gastric cancer. Cell Mol Life Sci. 2020;77(9):1661–1680.
   PubMed Web of Science ®Google Scholar
• Patop IL, Wust S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019;38(16):e100836.
   PubMed Web of Science ®Google Scholar
• Zong L, Sun Q, Zhang H, et al. Increased expression of circRNA_102231 in lung cancer and its clinical significance. Biomed Pharmacother. 2018;102:639–644.
   PubMed Web of Science ®Google Scholar
• Sun J, Li B, Shu C, et al. Functions and clinical significance of circular RNAs in glioma. Mol Cancer. 2020;19(1):34.
   PubMed Web of Science ®Google Scholar
• Shan C, Zhang Y, Hao X, et al. Biogenesis, functions and clinical significance of circRNAs in gastric cancer. Mol Cancer. 2019;18(1):136.
   PubMed Web of Science ®Google Scholar
• Liang G, Ling Y, Mehrpour M, et al. Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression. Mol Cancer. 2020;19(1):65.
   PubMed Web of Science ®Google Scholar
• Du J, Zhang G, Qiu H, et al. The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway. Cell Mol Biol Lett. 2019;24(1):72.
   PubMed Web of Science ®Google Scholar
• Huang Q, Guo H, Wang S, et al. A novel circular RNA, circXPO1, promotes lung adenocarcinoma progression by interacting with IGF2BP1. Cell Death Dis. 2020;11(12):1031.
   PubMed Web of Science ®Google Scholar
• Liang Y, Wang H, Chen B, et al. circDCUN1D4 suppresses tumor metastasis and glycolysis in lung adenocarcinoma by stabilizing TXNIP expression. Mol Ther Nucleic Acids. 2021;23:355–368.
   PubMedGoogle Scholar
• Gao L, Tian Q, Wu T, et al. Reduction of miR-744 delivered by NSCLC cell-derived extracellular vesicles upregulates SUV39H1 to promote NSCLC progression via activation of the Smad9/BMP9 axis. J Transl Med. 2021;19(1):37.
   PubMed Web of Science ®Google Scholar
• Shen X, Xu X, Xie C, et al. YAP promotes the proliferation of neuroblastoma cells through decreasing the nuclear location of p27(Kip1) mediated by Akt. Cell Prolif. 2020;53(2):e12734.
   PubMed Web of Science ®Google Scholar
• Han B, Zhang Y, Zhang Y, et al. Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke. Autophagy. 2018;14(7):1164–1184.
   PubMed Web of Science ®Google Scholar
• Dou Z, Xu C, Donahue G, et al. Autophagy mediates degradation of nuclear lamina. Nature (London). 2015;527(7576):105–109.
   PubMed Web of Science ®Google Scholar
• Zhou RS, Zhang EX, Sun QF, et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue. BMC Cancer. 2019;19(1):779.
   PubMed Web of Science ®Google Scholar
• Jiang LN, Ji X, Liu W, et al. Identification of the circ_PRKDC/miR-20a-3p/RASA1 axis in regulating HaCaT keratinocyte migration. Wound Repair Regen. 2021.
   Web of Science ®Google Scholar
• Yang J, Cheng M, Gu B, et al. CircRNA_09505 aggravates inflammation and joint damage in collagen-induced arthritis mice via miR-6089/AKT1/NF-kappaB axis. Cell Death Dis. 2020;11(10):833.
   PubMed Web of Science ®Google Scholar
• Otasek D, Morris JH, Boucas J, et al. Cytoscape Automation: empowering workflow-based network analysis. Genome Biol. 2019;20(1):185.
   PubMed Web of Science ®Google Scholar
• Zhao W, Wang J, Luo Q, et al. Identification of LINC02310 as an enhancer in lung adenocarcinoma and investigation of its regulatory network via comprehensive analyses. Bmc Med Genomics. 2020;13(1):185.
   PubMed Web of Science ®Google Scholar
• Chen A, Zhong L, Ju K, et al. Plasmatic circRNA predicting the occurrence of human glioblastoma. Cancer Manag Res. 2020;12:2917–2923.
   PubMed Web of Science ®Google Scholar
• Zhang G, Sun W, Zhu L, et al. Overexpressed circ_0029426 in glioblastoma forecasts unfavorable prognosis and promotes cell progression by sponging miR-197. J Cell Biochem. 2019;120(6):10295–10302.
   PubMed Web of Science ®Google Scholar
• Yu M, Yu J, and Zhang Y, et al. A novel circRNA-miRNA-mRNA network revealed exosomal circ-ATP10A as a biomarker for multiple myeloma angiogenesis. Bioengineered. 2021;13(1):667–683.
   Web of Science ®Google Scholar
• Liang ZZ, Guo C, Zou MM, et al. circRNA-miRNA-mRNA regulatory network in human lung cancer: an update. Cancer Cell Int. 2020;20:173.
   PubMed Web of Science ®Google Scholar
• Zuo H, Li X, Zheng X, et al. Novel circRNA-miRNA-mRNA hub regulatory network in lung adenocarcinoma. Front Genet. 2021;12:673501.
   PubMed Web of Science ®Google Scholar
• Sonkar K, Ayyappan V, Tressler CM, et al. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer. NMR Biomed. 2019;32(10):e4112.
   PubMed Web of Science ®Google Scholar
• Glunde K, Jacobs MA, Bhujwalla ZM. Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn. 2006 ;6(6):821–829.
   PubMed Web of Science ®Google Scholar
• Gallo RC. Research and discovery of the first human cancer virus, HTLV-1. Best Pract Res Clin Haematol. 2011;24(4):559–565.
   PubMed Web of Science ®Google Scholar
• Kairupan TS, Ibusuki R, Kheradmand M, et al. Interactions between inflammatory gene polymorphisms and HTLV-I infection for total death, incidence of cancer, and atherosclerosis-related diseases among the Japanese population. J Epidemiol. 2017;27(9):420–427.
   PubMed Web of Science ®Google Scholar
• Seo JS, Ju YS, Lee WC, et al. The transcriptional landscape and mutational profile of lung adenocarcinoma. Genome Res. 2012;22(11):2109–2119.
   PubMed Web of Science ®Google Scholar
• Shang Y, Li X, Liu W, et al. Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib. Sci Rep. 2020;10(1):20243.
   PubMed Web of Science ®Google Scholar
• Madsen RR, Vanhaesebroeck B, Semple RK. Cancer-associated PIK3CA mutations in overgrowth disorders. Trends Mol Med. 2018;24(10):856–870.
   PubMed Web of Science ®Google Scholar
• Kadara H, Choi M, Zhang J, et al. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up. Ann Oncol. 2017;28(1):75–82.
   PubMed Web of Science ®Google Scholar
• Chen S, Li F, Xu D, et al. The function of RAS mutation in cancer and advances in its drug research. Curr Pharm Des. 2019;25(10):1105–1114.
   PubMed Web of Science ®Google Scholar
• Cicenas J, Tamosaitis L, Kvederaviciute K, et al. KRAS, NRAS and BRAF mutations in colorectal cancer and melanoma. Med Oncol. 2017;34(2):26.
   PubMed Web of Science ®Google Scholar
• Shirazi F, Jones RJ, Singh RK, et al. Activating KRAS, NRAS, and BRAF mutants enhance proteasome capacity and reduce endoplasmic reticulum stress in multiple myeloma. Proc Natl Acad Sci U S A. 2020;117(33):20004–20014.
   PubMed Web of Science ®Google Scholar
• Timar J, Kashofer K. Molecular epidemiology and diagnostics of KRAS mutations in human cancer. Cancer Metastasis Rev. 2020;39(4):1029–1038.
   PubMed Web of Science ®Google Scholar
• Yalim-Camci I, Balcik-Ercin P, Cetin M, et al. ETS1 is coexpressed with ZEB2 and mediates ZEB2-induced epithelial-mesenchymal transition in human tumors. Mol Carcinog. 2019;58(6):1068–1081.
   PubMed Web of Science ®Google Scholar
• Dittmer J. The role of the transcription factor Ets1 in carcinoma. Semin Cancer Biol. 2015;35:20–38.
   PubMed Web of Science ®Google Scholar
• Wei J, Zhou Y, Jiang GQ, et al. Silencing of ETS1 reverses Adriamycin resistance in MCF-7/ADR cells via downregulation of MDR1. Cancer Cell Int. 2014;14(1):22.
   PubMedGoogle Scholar
• Tong L, Han WZ, Wang JL, et al. MicroRNA-365 inhibits the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway. Eur Rev Med Pharmacol Sci. 2020;24(9):4836–4845.
   PubMed Web of Science ®Google Scholar
• Sun Q, Jiang CW, Tan ZH, et al. MiR-222 promotes proliferation, migration and invasion of lung adenocarcinoma cells by targeting ETS1. Eur Rev Med Pharmacol Sci. 2017;21(10):2385–2391.
   PubMed Web of Science ®Google Scholar